Today, the U.S. Food and Drug Administration (FDA) announced that it is initiating action to remove concentrated ingestible fluoride prescription drug products for children from the market.

The American Association for Dental, Oral, and Craniofacial Research (AADOCR) has issued a strong condemnation of the recent Executive Order issued by the Trump administration entitled “Improving Oversight of Federal Grantmaking.” This directive mandates that political appointees be granted authority to review and potentially influence decisions on federal grant funding, a move that AADOCR warns could profoundly jeopardize the objectivity fundamental to scientific research.